Trial

NCT00702572

Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
Condition
Non-small Cell Lung Cancer
Intervention
Vorinostat, Bevacizumab, Carboplatin, Paclitaxel
Why stopped
Low Enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-22